부산대학교 도서관

Wahadat, A. R.; Tanis, W.; Galema, T. W.; Swart, L. E.; van Leeuwen, W. J.; Verkaik, N. J.; Schurink, C. A. M.; van Dalen, B.; Zoet-Nugteren, S.; Gurlek, C.; Budde, R. P. J.; Roos-Hesselink, J. W.

Netherlands Heart Journal. 31(1):29-35

N Roescher; JM Prins; JTM van der Meer; HI Bax; R Soetekouw; MGJ de Boer; LBS Gelinck; JJ Oosterheert; MA van Agtmael; M Berrevoets; DTP Buis; CH van Werkhoven; MJM Bonten; JE Bosmans; J Branger; S Douiyeb; E Jong; AJJ Lammers; E Sieswerda; JE Stalenhoef; TW Van der Vaart; EA Bij de Vaate; NJ Verkaik; MGA Van Vonderen; PJ De Vries; KCE Sigaloff; E Botman; A Van den Broek; L Buitenhuis; E Buitenwerf; A S Cents; N Engels; J L J Hanssen; A J Meinders; F P N Mollema; L Nagelmaker; M L M van Doorn-Schepens; P Thomopoulos; M Timmer; B van der Wiel

BMJ Open, Vol 13, Iss 4 (2023)

Witteveen S; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Hans JB; German National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.; Izdebski R; Departement of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.; Hasman H; National Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.; Samuelsen Ø; Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.; Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.; Dortet L; French National Reference Center for Antimicrobial Resistance, INSERM UMR 1184, Paris-Saclay University, Bicêtre Hospital, Assistance Publique des Hôpitaux de Paris, Paris, France.; Pfeifer Y; Division of Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, Wernigerode Branch, Wernigerode, Germany.; Delappe N; University of Galway, Galway, Ireland.; Oteo-Iglesias J; Reference and Research Laboratory on Antibiotic Resistance of the National Center for Microbiology and CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Żabicka D; Departement of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.; Cormican M; University of Galway, Galway, Ireland.; Sandfort M; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.; Reichert F; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.; Pöntinen AK; Department of Biostatistics, Faculty of Medicine, University of Oslo, Oslo, Norway.; Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.; Fischer MA; Division of Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, Wernigerode Branch, Wernigerode, Germany.; Verkaik N; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands.; Pérez-Vazquez M; Reference and Research Laboratory on Antibiotic Resistance of the National Center for Microbiology and CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Pfennigwerth N; German National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.; Hammerum AM; National Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.; Hallstrøm S; National Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.; Biedrzycka M; Departement of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.; Räisänen K; Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland.; Wielders CC; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Urbanowicz P; Departement of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.; de Haan A; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Westmo K; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.; Landman F; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; van der Heide HG; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Lansu S; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Zwittink RD; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Notermans DW; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Guzek A; Department of Laboratory Diagnostics, Section of Microbiology, Military Institute of Medicine - National Research Institute, Warsaw, Poland.; Kondratiuk V; National Pirogov Memorial University, Vinnytsia, Ukraine.; Salmanov A; Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.; Haller S; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.; Linkevicius M; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.; Gatermann S; German National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.; Kohlenberg A; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.; Gniadkowski M; Departement of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.; Werner G; Division of Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, Wernigerode Branch, Wernigerode, Germany.; Hendrickx AP; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE

Wahadat, A. R.; Deckers, J. W.; Budde, R. P. J.; van der Meer, J. T. M.; Natour, E. H.; ten Oever, J.; Kortlever-van der Spek, A. L. J.; Stegeman, B. H.; Verkaik, N. J.; Roos-Hesselink, J. W.; Tanis, W.

Netherlands Heart Journal. 28(12):628-636

Buis, D. T.P.; Van Werkhoven, C. H.; Van Agtmael, M. A.; Bax, H. I.; Berrevoets, M.; De Boer, M. G.J.; Bonten, M. J.M.; Bosmans, J. E.; Branger, J.; Douiyeb, S.; Gelinck, L. B.S.; Jong, E.; Lammers, A. J.J.; Van Der Meer, J. T.M.; Oosterheert, J. J.; Sieswerda, E.; Soetekouw, R.; Stalenhoef, J. E.; Van Der Vaart, T. W.; Bij De Vaate, E. A.; Verkaik, N. J.; Van Vonderen, M. G.A.; De Vries, P. J.; Prins, J. M.; Sigaloff, K. C.E.

Buis , D T P , Van Werkhoven , C H , Van Agtmael , M A , Bax , H I , Berrevoets , M , De Boer , M G J , Bonten , M J M , Bosmans , J E , Branger , J , Douiyeb , S , Gelinck , L B S , Jong , E , Lammers , A J J , Van Der Meer , J T M , Oosterheert , J J , Sieswerda , E , Soetekouw , R , Stalenhoef , J E , Van Der Vaart , T W , Bij De Vaate , E A , Verkaik , N J , Van Vonderen , M G A , De Vries , P J , Prins , J M & Sigaloff , K C E 2023 , ' Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial) : Protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment ' , BMJ Open , vol. 13 , no. 4 , e068295 .

Helou, R. I.; Foudraine, D. E.; Catho, G.; Peyravi Latif, Annabel; Verkaik, N. J.; Verbon, A.

PLOS ONE. 15(9)

R I Helou; D E Foudraine; G Catho; A Peyravi Latif; N J Verkaik; A Verbon

PLoS ONE, Vol 15, Iss 9, p e0239751 (2020)

Karolin F. Meyer; Rikst Nynke Verkaik-Schakel; Wim Timens; Lester Kobzik; Torsten Plösch; Machteld N. Hylkema

Epigenetics, Vol 12, Iss 12, Pp 1076-1091 (2017)

Dräger S; Department of Hospital Pharmacy, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Rotterdam Clinical Pharmacometrics Group, 3015 GD Rotterdam, The Netherlands.; Department of Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland.; Ewoldt TMJ; Department of Hospital Pharmacy, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Rotterdam Clinical Pharmacometrics Group, 3015 GD Rotterdam, The Netherlands.; Department of Intensive Care Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Abdulla A; Department of Hospital Pharmacy, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Rotterdam Clinical Pharmacometrics Group, 3015 GD Rotterdam, The Netherlands.; Rietdijk WJR; Department of Hospital Pharmacy, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Institutional Affairs, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.; Verkaik N; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.; Ramakers C; Department of Clinical Chemistry, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.; de Jong E; Department of Intensive Care, Rode Kruis Ziekenhuis, 1942 LE Beverwijk, The Netherlands.; Osthoff M; Department of Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland.; Koch BCP; Department of Hospital Pharmacy, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Rotterdam Clinical Pharmacometrics Group, 3015 GD Rotterdam, The Netherlands.; Endeman H; Department of Intensive Care Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE

Buis, D. T. P.; van Werkhoven, C. H.; van Agtmael, M. A.; Bax, H. I.; Berrevoets, M.; de Boer, M. G. J.; Bonten, M. J. M.; Bosmans, J. E.; Branger, J.; Douiyeb, S.; Gelinck, L. B. S.; Jong, E.; Lammers, A. J. J.; Van der Meer, J. T. M.; Oosterheert, J. J.; Sieswerda, E.; Soetekouw, R.; Stalenhoef, J. E.; Van der Vaart, T. W.; de Vaate, E. A. Bij; Verkaik, N. J.; Van Vonderen, M. G. A.; De Vries, P. J.; Prins, J. M.; Sigaloff, K. C. E.; Collaborators SAFE-Trial Study Grp

BMJ OPEN; APR 2023, 13 4, pe068295 9p.